The latest report by IMARC Group, titled “Biophotonics Market Report by Technique (Surface Imaging, Molecular Spectroscopy, Microscopy, Light Therapy, Biosensors, Inside Imaging, See-through Imaging, and Others), Technology (In-Vitro, In-Vivo), Application (Medical Diagnostics, Medical Therapeutics, Material Testing, and Others), and Region 2025-2033,” finds that the global biophotonics market reached a value of USD 59.5 Billion in 2024. Biophotonics is the interdisciplinary research area that deals with light-based technologies to study life sciences and medicine. It generates and harnesses light to visualize, detect and manipulate biological materials. Biophotonics also uses light and other forms of radiant energy to study the internal functioning of cells and tissues and analyze molecular mechanisms, functions and structures. Biophotonics utilizes various techniques, such as spectroscopy, photomechanics, and fiber optic sensors based on see-through imaging. It aids in the emission, detection, absorption, reflection, and modification of radiations from biomolecules and biomaterials.
Global Biophotonics Market Trends:
The global biophotonics market is primarily driven by its increasing adoption in the medical sector. It is used in healthcare instruments and components for improving accuracy and sensitivity. The rising cases of chronic diseases, especially among the geriatric population, which is more susceptible to these ailments, are also propelling the market growth. Besides this, governments of various countries are taking initiatives and creating awareness regarding the benefits of biophotonics. In addition to this, the emergence of nanotechnology and biosensors has increased the use of biophotonics in non-medical sectors for testing toxins, chemicals and microbial materials for defense and environmental monitoring applications. Furthermore, the growing demand for home-based point-of-care (POC) devices and improvements in optical technologies are positively influencing the market growth. Looking forward, IMARC Group expects the market to reach USD 127.7 Billion by 2033, exhibiting a growth rate (CAGR) of 8.41% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Technique, Technology, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Andor Technology Ltd. (Oxford Instruments Plc), BD (Becton, Dickinson and Company), Carl Zeiss AG (Carl-Zeiss-Stiftung), Glenbrook Technologies Inc., Hamamatsu Photonics K.K, Lumenis Ltd., Olympus Corporation, Perkinelmer Inc., Thermo Fisher Scientific Inc. and Zecotek Photonics Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800